Clinical Trials Browser

Phase 1 × Sorafenib × Other neoplasm × Clear all

NCT00244972 2017-04-27

Tipifarnib and Sorafenib Tosylate in Treating Patients With Biopsiable Advanced Cancer

Phase 1 Completed

Advanced Malignant Neoplasm